JODI CONLEY: Open Payments
NPI 1891860599 · GRAYSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 57 payments from 22 companies in 2025. Trend: 2023 $1,272 · 2024 $1,196 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $160 |
| GlaxoSmithKline, LLC. | 9 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $135 |
| Grifols USA, LLC | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Lilly USA, LLC | 3 | $45 |
| ABBVIE INC. | 2 | $37 |
| Verona Pharma, Inc. | 2 | $37 |
| Corcept Therapeutics | 2 | $36 |
| PFIZER INC. | 2 | $34 |
Products named: TRELEGY ELLIPTA, CAPLYTA, Wegovy, Prolastin-C Liquid, MOUNJARO, Rybelsus, VRAYLAR, Ohtuvayre.
Industry payments across KY — which companies pay providers there.
